This site is intended for a global audience
Contact Us
ProgramZanidatamab (ZW25)
StudyHERIZON-BTC-01
TitleA Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers (HERIZON-BTC-01)
NCT NumberNCT04466891
Link to view PLSClick to view summary

Disclaimer: The purpose of plain language summaries is to provide clinical trial results in an easy-to-understand format. Plain language summaries are not intended for any promotional purposes or as a replacement or substitute for medical advice provided by your doctor or healthcare provider. It is important for you to discuss your treatment options, and any questions that you may have, with your doctor or healthcare provider. You should not use this website to diagnose or treat a health problem or disease.